+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Thyroid Gland Disorder Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 300 Pages
  • October 2023
  • Region: Global
  • Infinium Global Research
  • ID: 5898339
Description Jump to:
The report on the global thyroid gland disorder treatment market provides qualitative and quantitative analysis for the period from 2021-2030. The global thyroid gland disorder treatment market was valued at USD 2.26 billion in 2022 and is expected to reach USD 3.15 billion in 2030, with a CAGR of 3.67% during the forecast period 2023-2030. The study on thyroid gland disorder treatment market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The thyroid gland disorder treatment market encompasses the production, distribution, and sale of products and services aimed at addressing various thyroid gland-related medical conditions. This market primarily includes pharmaceuticals, diagnostic tools, and therapeutic procedures, catering to patients with conditions like hypothyroidism, hyperthyroidism, goiter, and thyroid cancer. Key components of this market include prescription medications, surgical interventions, and diagnostic tests for accurate diagnosis and monitoring. Companies operating in this market range from pharmaceutical giants developing hormone replacement therapies to diagnostic equipment manufacturers and healthcare providers offering surgical and non-surgical treatments. The thyroid gland disorder treatment market represents a significant segment within the broader healthcare industry, offering opportunities for growth and innovation as advancements in medical science and technology continue to shape the landscape.

The thyroid gland disorder treatment market is driven by the escalating incidence of thyroid disorders and the expansion of awareness and screening initiatives. The surge in thyroid disorders, encompassing hypothyroidism, hyperthyroidism, and thyroid cancer, is a central driver, primarily fueled by shifting lifestyles, environmental influences, and enhanced diagnostic capabilities. The heightened consciousness of thyroid health and the execution of screening and early detection programs have augmented case identification, thereby stimulating the demand for treatments. Additionally, the development of efficacious combination drug therapies for thyroid disorders plays a pivotal role in the expansion of the thyroid disorder treatment market. These innovative drug combinations not only offer superior patient outcomes with reduced side effects but also bolster the market's growth and competitiveness. However, it's worth noting that side effects leading to reduced patient adherence can significantly constrain the market's progression. The evolving healthcare trends and advances in medical research present promising opportunities for the market.

North America is expected to dominate the market share in the upcoming forecast period. North America maintains a stronghold in the thyroid disorder treatment market owing to its elevated incidence of thyroid disorders, robust and mature healthcare infrastructure, and booming pharmaceutical and biotechnology sector, which collectively foster cutting-edge research and advanced treatment options. On the other hand, the Asia-Pacific (APAC) region is emerging as the fastest-growing market segment due to substantial investments in healthcare infrastructure, expanding access to medical facilities, and notable technological advancements. These developments have significantly enhanced the capability for timely diagnosis and effective treatment of thyroid disorders in the region, reflecting a burgeoning market potential for healthcare stakeholders and industry players.

Report Findings

1) Drivers

  • The thyroid gland disorder treatment market is driven by the escalating incidence of thyroid disorders and the expansion of awareness and screening initiatives.
  • The development of efficacious combination drug therapies for thyroid disorders plays a pivotal role in the expansion of the thyroid disorder treatment market.

2) Restraints

  • The side effects leading to reduced patient adherence can significantly constrain the market's progression.

3) Opportunities

  • The evolving healthcare trends and advances in medical research present promising opportunities for the market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents.

The primary respondents approached include:

1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global thyroid gland disorder treatment market is segmented on the basis of disease type, drug type, route of administration, and distribution/sales channel.

The Global Thyroid Gland Disorder Treatment Market by Disease Type

  • Hyperthyroidism
  • Hypothyroidism

The Global Thyroid Gland Disorder Treatment Market by Drug Type

  • Levothyroxine
  • Liothyronine
  • Propylthiouracil
  • Imidazole-based Compound
  • Others

The Global Thyroid Gland Disorder Treatment Market by Route of Administration

  • Oral
  • Intravenous
  • Others

The Global Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel

  • Wholesaler/Distributor
  • Retailer
  • Mail-order Pharmacy
  • Others

Company Profiles

The companies covered in the report include:

  • GSK plc
  • Pfizer Inc.
  • Allergan acquired by (AbbVie)
  • AbbVie Inc.
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Mylan (Now a Part of Viatris)
  • Lannett Co Inc
  • RLC LABS

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the thyroid gland disorder treatment market.

2. Complete coverage of all the segments in the thyroid gland disorder treatment market to analyze the trends, developments in the global market and forecast of market size up to 2030.

3. Comprehensive analysis of the companies operating in the global thyroid gland disorder treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. The Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Thyroid Gland Disorder Treatment Market Highlights
2.2. Thyroid Gland Disorder Treatment Market Projection
2.3. Thyroid Gland Disorder Treatment Market Regional Highlights
Chapter 3. Global Thyroid Gland Disorder Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Disease Type
3.4.2. Growth Matrix Analysis by Drug Type
3.4.3. Growth Matrix Analysis by Route of Administration
3.4.4. Growth Matrix Analysis by Distribution/Sales Channel
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Thyroid Gland Disorder Treatment Market
Chapter 4. Thyroid Gland Disorder Treatment Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Thyroid Gland Disorder Treatment Market
5.2. Companies Profiles
5.2.1. GSK plc
5.2.2. Pfizer Inc.
5.2.3. Allergan acquired by (AbbVie)
5.2.4. AbbVie Inc.
5.2.5. Abbott Laboratories
5.2.6. Merck & Co., Inc.
5.2.7. Novartis AG
5.2.8. Mylan (Now a Part of Viatris)
5.2.9. Lannett Co Inc
5.2.10. RLC LABS
Chapter 6. Global Thyroid Gland Disorder Treatment Market by Disease Type
6.1. Hyperthyroidism
6.2. Hypothyroidism
Chapter 7. Global Thyroid Gland Disorder Treatment Market by Drug Type
7.1. Levothyroxine
7.2. Liothyronine
7.3. Propylthiouracil
7.4. Imidazole-based Compound
7.5. Others
Chapter 8. Global Thyroid Gland Disorder Treatment Market by Route of Administration
8.1. Oral
8.2. Intravenous
8.3. Others
Chapter 9. Global Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
9.1. Wholesaler/Distributor
9.2. Retailer
9.3. Mail-order Pharmacy
9.4. Others
Chapter 10. Global Thyroid Gland Disorder Treatment Market by Region 2023-2030
10.1. North America
10.1.1. North America Thyroid Gland Disorder Treatment Market by Disease Type
10.1.2. North America Thyroid Gland Disorder Treatment Market by Drug Type
10.1.3. North America Thyroid Gland Disorder Treatment Market by Route of Administration
10.1.4. North America Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.1.5. North America Thyroid Gland Disorder Treatment Market by Country
10.1.5.1. The U.S. Thyroid Gland Disorder Treatment Market
10.1.5.1.1. The U.S. Thyroid Gland Disorder Treatment Market by Disease Type
10.1.5.1.2. The U.S. Thyroid Gland Disorder Treatment Market by Drug Type
10.1.5.1.3. The U.S. Thyroid Gland Disorder Treatment Market by Route of Administration
10.1.5.1.4. The U.S. Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.1.5.2. Canada Thyroid Gland Disorder Treatment Market
10.1.5.2.1. Canada Thyroid Gland Disorder Treatment Market by Disease Type
10.1.5.2.2. Canada Thyroid Gland Disorder Treatment Market by Drug Type
10.1.5.2.3. Canada Thyroid Gland Disorder Treatment Market by Route of Administration
10.1.5.2.4. Canada Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.1.5.3. Mexico Thyroid Gland Disorder Treatment Market
10.1.5.3.1. Mexico Thyroid Gland Disorder Treatment Market by Disease Type
10.1.5.3.2. Mexico Thyroid Gland Disorder Treatment Market by Drug Type
10.1.5.3.3. Mexico Thyroid Gland Disorder Treatment Market by Route of Administration
10.1.5.3.4. Mexico Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.2. Europe
10.2.1. Europe Thyroid Gland Disorder Treatment Market by Disease Type
10.2.2. Europe Thyroid Gland Disorder Treatment Market by Drug Type
10.2.3. Europe Thyroid Gland Disorder Treatment Market by Route of Administration
10.2.4. Europe Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.2.5. Europe Thyroid Gland Disorder Treatment Market by Country
10.2.5.1. Germany Thyroid Gland Disorder Treatment Market
10.2.5.1.1. Germany Thyroid Gland Disorder Treatment Market by Disease Type
10.2.5.1.2. Germany Thyroid Gland Disorder Treatment Market by Drug Type
10.2.5.1.3. Germany Thyroid Gland Disorder Treatment Market by Route of Administration
10.2.5.1.4. Germany Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.2.5.2. United Kingdom Thyroid Gland Disorder Treatment Market
10.2.5.2.1. United Kingdom Thyroid Gland Disorder Treatment Market by Disease Type
10.2.5.2.2. United Kingdom Thyroid Gland Disorder Treatment Market by Drug Type
10.2.5.2.3. United Kingdom Thyroid Gland Disorder Treatment Market by Route of Administration
10.2.5.2.4. United Kingdom Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.2.5.3. France Thyroid Gland Disorder Treatment Market
10.2.5.3.1. France Thyroid Gland Disorder Treatment Market by Disease Type
10.2.5.3.2. France Thyroid Gland Disorder Treatment Market by Drug Type
10.2.5.3.3. France Thyroid Gland Disorder Treatment Market by Route of Administration
10.2.5.3.4. France Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.2.5.4. Italy Thyroid Gland Disorder Treatment Market
10.2.5.4.1. Italy Thyroid Gland Disorder Treatment Market by Disease Type
10.2.5.4.2. Italy Thyroid Gland Disorder Treatment Market by Drug Type
10.2.5.4.3. Italy Thyroid Gland Disorder Treatment Market by Route of Administration
10.2.5.4.4. Italy Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.2.5.5. Rest of Europe Thyroid Gland Disorder Treatment Market
10.2.5.5.1. Rest of Europe Thyroid Gland Disorder Treatment Market by Disease Type
10.2.5.5.2. Rest of Europe Thyroid Gland Disorder Treatment Market by Drug Type
10.2.5.5.3. Rest of Europe Thyroid Gland Disorder Treatment Market by Route of Administration
10.2.5.5.4. Rest of Europe Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3. Asia Pacific
10.3.1. Asia Pacific Thyroid Gland Disorder Treatment Market by Disease Type
10.3.2. Asia Pacific Thyroid Gland Disorder Treatment Market by Drug Type
10.3.3. Asia Pacific Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.4. Asia Pacific Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3.5. Asia Pacific Thyroid Gland Disorder Treatment Market by Country
10.3.5.1. China Thyroid Gland Disorder Treatment Market
10.3.5.1.1. China Thyroid Gland Disorder Treatment Market by Disease Type
10.3.5.1.2. China Thyroid Gland Disorder Treatment Market by Drug Type
10.3.5.1.3. China Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.5.1.4. China Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3.5.2. Japan Thyroid Gland Disorder Treatment Market
10.3.5.2.1. Japan Thyroid Gland Disorder Treatment Market by Disease Type
10.3.5.2.2. Japan Thyroid Gland Disorder Treatment Market by Drug Type
10.3.5.2.3. Japan Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.5.2.4. Japan Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3.5.3. India Thyroid Gland Disorder Treatment Market
10.3.5.3.1. India Thyroid Gland Disorder Treatment Market by Disease Type
10.3.5.3.2. India Thyroid Gland Disorder Treatment Market by Drug Type
10.3.5.3.3. India Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.5.3.4. India Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3.5.4. South Korea Thyroid Gland Disorder Treatment Market
10.3.5.4.1. South Korea Thyroid Gland Disorder Treatment Market by Disease Type
10.3.5.4.2. South Korea Thyroid Gland Disorder Treatment Market by Drug Type
10.3.5.4.3. South Korea Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.5.4.4. South Korea Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3.5.5. Australia Thyroid Gland Disorder Treatment Market
10.3.5.5.1. Australia Thyroid Gland Disorder Treatment Market by Disease Type
10.3.5.5.2. Australia Thyroid Gland Disorder Treatment Market by Drug Type
10.3.5.5.3. Australia Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.5.5.4. Australia Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.3.5.6. Rest of Asia-Pacific Thyroid Gland Disorder Treatment Market
10.3.5.6.1. Rest of Asia-Pacific Thyroid Gland Disorder Treatment Market by Disease Type
10.3.5.6.2. Rest of Asia-Pacific Thyroid Gland Disorder Treatment Market by Drug Type
10.3.5.6.3. Rest of Asia-Pacific Thyroid Gland Disorder Treatment Market by Route of Administration
10.3.5.6.4. Rest of Asia-Pacific Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.4. RoW
10.4.1. RoW Thyroid Gland Disorder Treatment Market by Disease Type
10.4.2. RoW Thyroid Gland Disorder Treatment Market by Drug Type
10.4.3. RoW Thyroid Gland Disorder Treatment Market by Route of Administration
10.4.4. RoW Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.4.5. RoW Thyroid Gland Disorder Treatment Market by Sub-region
10.4.5.1. Latin America Thyroid Gland Disorder Treatment Market
10.4.5.1.1. Latin America Thyroid Gland Disorder Treatment Market by Disease Type
10.4.5.1.2. Latin America Thyroid Gland Disorder Treatment Market by Drug Type
10.4.5.1.3. Latin America Thyroid Gland Disorder Treatment Market by Route of Administration
10.4.5.1.4. Latin America Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.4.5.2. Middle East Thyroid Gland Disorder Treatment Market
10.4.5.2.1. Middle East Thyroid Gland Disorder Treatment Market by Disease Type
10.4.5.2.2. Middle East Thyroid Gland Disorder Treatment Market by Drug Type
10.4.5.2.3. Middle East Thyroid Gland Disorder Treatment Market by Route of Administration
10.4.5.2.4. Middle East Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel
10.4.5.3. Africa Thyroid Gland Disorder Treatment Market
10.4.5.3.1. Africa Thyroid Gland Disorder Treatment Market by Disease Type
10.4.5.3.2. Africa Thyroid Gland Disorder Treatment Market by Drug Type
10.4.5.3.3. Africa Thyroid Gland Disorder Treatment Market by Route of Administration
10.4.5.3.4. Africa Thyroid Gland Disorder Treatment Market by Distribution/Sales Channel

Companies Mentioned

  • GSK plc
  • Pfizer Inc.
  • Allergan acquired by (AbbVie)
  • AbbVie Inc.
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Mylan (Now a Part of Viatris)
  • Lannett Co Inc
  • RLC LABS

Table Information

Report AttributeDetails
No. of Pages300
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.26 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.15 Billion
Compound Annual Growth Rate3.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Thyroid Gland Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Thyroid Gland Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Thyroid Gland Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Thyroid Gland Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 181 Pages
  • Global
From
Thyroid Gland Disorder Treatment - Global Strategic Business Report - Product Image

Thyroid Gland Disorder Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Thyroid Gland Disorder Treatment Market 2024-2028 - Product Image

Thyroid Gland Disorder Treatment Market 2024-2028

  • Report
  • 163 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.